Greenwich Biosciences is the US leader in the field of cannabinoid prescription medicines.

Read More

Scroll Arrow Icon

PRESS RELEASE

FDA Approves EPIDIOLEX® (cannabidiol) Oral Solution to Treat Seizures Associated with Tuberous Sclerosis Complex

Read More

   
 
 
 

OUR PROMISE

We’ve achieved this distinction because we made a promise to our patients and caregivers to look at things differently.

Learn More

Scroll Arrow Icon

WHO WE ARE

It is our passion and purpose to continually seek solutions that transform the lives of those living with rare and severe neurological diseases.

   
 
 
 

MEDICAL INFORMATION

Access scientific and clinical information on Greenwich Biosciences products.

Read More

Scroll Arrow Icon

INQUIRIES

Healthcare professionals can find scientific and clinical information about Greenwich Biosciences products and submit medical inquiries for additional information.

   
 
 
 

SPOTLIGHT ARTICLES

March 20, 2019

Overcoming Challenges in the Diagnosis of Rare Childhood-onset Epilepsies

Read More

 
 
 

PRESS RELEASES

Exciting things are happening at Greenwich Biosciences. See the latest news about our company, products, and pipeline.

Read More

   
 
 
 

PATIENTS & CAREGIVERS

"Our primary purpose is to make a positive and meaningful difference in the lives of patients and their caregivers."

– Justin Gover, Chief Executive Officer

Scroll Arrow Icon

FROM THE BEGINNING

Greenwich Biosciences puts patients at the center — and at the start.

   
 
 
 

Become part of a dynamic, cutting-edge pharmaceutical company on the forefront of therapeutic treatment.

View Careers

Scroll Arrow Icon